Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.53 |
| ▸ | PRKDC | P78527 | 6/20 | 0.45 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.43 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.36 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.34 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.34 |
| ▸ | PLA2G2A | P14555 | 4/20 | 0.32 |
| ▸ | PLA2G4A | P47712 | 4/20 | 0.32 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17248339 | 0.99 | ALOX5 (0.54) | ALOX5PRKDCGGPS1PTGES2ATM | |
| SCHEMBL15630572 | 0.95 | ALOX5 (0.56) | ALOX5PRKDCGGPS1PTGES2ATM | |
| SCHEMBL13830071 | 0.95 | ALOX5 (0.56) | ALOX5PRKDCGGPS1PTGES2ATM | |
| SCHEMBL22106831 | 0.94 | ALOX5 (0.54) | ALOX5PRKDCGGPS1PTGES2ATM | |
| SCHEMBL13829522 | 0.94 | ALOX5 (0.54) | ALOX5PRKDCGGPS1PTGES2ATM | |
| SCHEMBL22106837 | 0.92 | ALOX5 (0.48) | ALOX5PRKDCGGPS1PTGES2ATM | |
| SCHEMBL16442650 | 0.91 | ALOX5 (0.46) | ALOX5PRKDCGGPS1PTGES2ATM | |
| SCHEMBL26530238 | 0.91 | ALOX5 (0.54) | ALOX5PRKDCGGPS1PTGES2ATM | |
| SCHEMBL5029690 | 0.91 | ALOX5 (0.47) | ALOX5PRKDCGGPS1PTGES2ATM | |
| SCHEMBL10092199 | 0.91 | ALOX5 (0.47) | ALOX5PRKDCGGPS1PTGES2ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130119360-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME | MERCK PATENT GMBH (DE) | 2013-05-16 | — | — | US | disclosed |
| US-8367224-B2 | Organic electroluminescence element, new compound for the same, display device and lighting device using the same | KONICA MINOLTA HOLDINGS, INC. (JP) | 2013-02-05 | — | — | US | disclosed |
| EP-2453496-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, NOVEL COMPOUND, LIGHTING DEVICE AND DISPLAY DEVICE | Konica Minolta Holdings, Inc. (JP) | 2012-05-16 | — | — | EP | disclosed |
| US-20110006670-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-01-13 | — | — | US | disclosed |
| US-20110006670-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110006670-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME | AOC2, AOC3, CDYL | ALOX5 855/4885PRKDC 3081/4885GGPS1 2906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.